RAAQ

ANALYST NOTE: RAAQ (Real Asset Acquisition Corp.) Date: 2026-06-20 Current Price: $10.47

1. Structural Readiness

• State: Forming.
• Conservative Entry: Not yet actionable. A conservative entry requires a confirmed breakout above the resistance structure (typically the high of the consolidation range) with volume confirmation.
• Aggressive/Pre-Breakout Entry: Not recommended as a standalone signal. The current price of $10.47 represents a "holding" zone above the invalidation line, but lacks the structural momentum of a confirmed breakout.
• Breakout Level: The breakout level is the high of the current consolidation range. This level has not been tested or breached as of the latest close.
• Current Price: $10.47.
• Extension: N/A (Price is within the consolidation range, not extended above resistance).
• ATR Context: Current ATR is 2.9% (productive). This indicates moderate volatility suitable for position sizing but does not yet signal the "high" volatility (4-6%) often associated with confirmed breakout momentum.
• Classification: FORMING. The setup is live and holding above the invalidation line, but the "breakout" signal has not fired. This is a partial readiness signal, not a confirmed trade.

2. Thesis Layer

• Thesis Type: TACTICAL / SETUP-LED.
• Macro Thesis: There is NO named secular thesis attached to RAAQ as of this date. The investment case is not driven by a specific macroeconomic theme (e.g., "AI Infrastructure" or "Green Energy Transition") but is strictly dependent on the successful execution of the business combination transaction and the structural setup of the stock price.

3. Business & Fundamentals

• Business Model: RAAQ is a Special Purpose Acquisition Company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
• Industry: Financial Services (specifically, SPACs/Investment Vehicles).
• Current Status (as of 2026-06-20): The company is in the final stages of executing a business combination.
• Transaction Timeline: Management expects the closing of the transaction to occur in the third quarter of 2026. This is subject to shareholder and regulatory approval (Evidence E1, E7).
• Completion Deadline: The company has until January 30, 2027, to complete the business combination, which is 21 months from the IPO date (Evidence E2).
• Funding Strategy: The transaction is expected to be funded by a combination of funds held in the Trust Account and expected proceeds from a public investment in private equity (Evidence E3, E6).
• Liquidity Position: As of March 31, 2026, the company held $838,494 in cash and cash equivalents outside the trust, with a working capital surplus of $822,694 (Evidence E4).
• Trust Account: The Trust Account holds $178,582,603 in U.S. government treasury bills maturing within three months (Evidence E5).
• IPO History: The company consummated its IPO on April 30, 2025, selling 17,250,000 units (including over-allotment) for gross proceeds of $172,500,000 (Evidence E8).
• Management Intent: Management explicitly states they intend to use substantially all funds in the Trust Account, including interest earned (net of taxes), to complete the initial business combination (Evidence E10). They continue to seek completion prior to the mandatory liquidation date (Evidence E9).

4. Archetype & Conviction

• Archetype: Structural Completion / Event-Driven.
• This is not a traditional growth, value, or cyclical archetype. It is an event-driven vehicle where the "business" is the successful closing of a merger. The archetype is defined by the binary nature of the outcome: successful combination (value realization) or liquidation (value erosion).
• Valuation Context: The valuation is currently anchored to the Trust Account value per share. With ~$178.5M in the trust and 17.25M shares outstanding, the implied trust value per share is approximately $10.35. The current market price of $10.47 suggests a slight premium to the trust value, likely reflecting the market's expectation of the deal closing and potential upside from the PIPE (Private Investment in Public Equity) or the target company's growth prospects.
• Conviction Stack:
• Thesis Strength: Low (No macro thesis; purely tactical).
• Evidence Quality: High (Clear, recent SEC filings confirm timeline and liquidity).
• Setup Readiness: Partial (Waiting for Q3 2026 closing or breakout).
• Rerating Potential: Dependent entirely on the announcement of the specific target and the terms of the deal.
• ATR Analysis: The current ATR of 2.9% is in the "productive" range, indicating the stock is not stagnant but lacks the explosive volatility (4-6%) of a confirmed breakout. This supports the "Forming" classification.

5. Invalidations, Strengths, and Gaps

• What Would Invalidate:
• A public announcement that the transaction will not close in Q3 2026 or that the deadline (Jan 30, 2027) will be missed.
• A significant drop in the Trust Account value due to unanticipated losses or early withdrawals.
• What Would Strengthen:
• A confirmed announcement of the specific target company and deal terms.
• A confirmed closing of the transaction in Q3 2026.
• A price breakout above the consolidation range with volume, confirming the "Forming" coil into a "Confirmed" coil.
• Gaps in Evidence:
• Target Identity: The specific target company for the business combination is not named in the provided evidence. This is a critical gap for fundamental valuation.
• Deal Terms: The specific valuation of the target, the size of the PIPE investment, and the pro-forma ownership structure are missing.
• Management Track Record: No specific details on the management team's past success rates in closing SPAC deals are provided in the evidence block.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key risks: Target company identity remains undisclosed; Regulatory or shareholder approval could fail; Liquidation risk if deal not closed by Jan 30, 2027; No macro thesis to support premium valuation. Sizing hint: Position size should be limited to reflect the binary nature of the event and the lack of a confirmed breakout; treat as a tactical satellite holding. Expected path: Management expects deal closure in Q3 2026; price likely to consolidate near trust value until deal terms are announced, followed by a potential breakout if deal is favorable. Expected horizon: 3 to 6 months (aligned with Q3 2026 closing window).